Athanor Capital, LP Avidity Biosciences, Inc. Transaction History

Athanor Capital, LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 14, 2021	SELL	$20.28 - $28.15 $213,406 - $296,222	-10,523 Closed	0 $0
Q4 2020 Feb 16, 2021	SELL	$24.73 - $35.12 $15,728 - $22,336	-636 Reduced 5.7%	10,523 $269,000
Q3 2020 Nov 16, 2020	BUY	$23.35 - $35.94 $77,381 - $119,105	3,314 Added 42.24%	11,159 $314,000
Q2 2020 Aug 13, 2020	BUY	$26.62 - $31.5 $208,833 - $247,117	7,845 New	7,845 $222,000

256

107M

224K

161K

Ticker RNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 52,127,000
Market Cap $2.26B
Description
Avidity Biosciences, Inc., a biopharmaceutical company, engages in the development of oligonucleotide-based therapies. It develops antibody oligonucleotide conjugates (AOC) that are designed to treat a range of serious diseases. The company's lead product candidate AOC 1001 is used for the treatment of myotonic dystrophy type 1, a rare monogenic...

Get notified when there are updates to the investment portfolio of Athanor Capital, LP, based on Form 13F filings with the SEC.

Stay updated on Athanor Capital, LP with notifications on news.